Annabelle Santos Volgman to Biomarkers
This is a "connection" page, showing publications Annabelle Santos Volgman has written about Biomarkers.
Connection Strength
0.310
-
The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease. J Alzheimers Dis. 2024; 100(4):1407-1416.
Score: 0.181
-
A multidomain trial for cognition in women with cardiovascular disease. Alzheimers Dement. 2025 06; 21(6):e70285.
Score: 0.050
-
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
Score: 0.041
-
The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
Score: 0.038